-
Recent findings from the Centers for Disease Control and Prevention reveal a staggering threefold increase in reported cases of vector-borne diseases between 2004 and 2016 in the United States. Making matters worse, nine new pathogens [Read more] -
Vaccinations have begun in a first-in-human trial of an experimental Zika virus vaccine, the National Institute of Allergy and Infectious Diseases (NIAID) announced today. The experimental vaccine, known as rZIKV/D4Δ30-713, was developed in NIAID’s Laboratory [Read more] -
See what we’re reading this week at Global Biodefense on topics including the difficulties of containing Ebola in a conflict zone, mining data to predict toxicological properties, and measles spreading to Brazil from the Venezuela crisis. POLICY [Read more] -
By Saskia Popescu What do three days of a workshop on all things from anthrax to Zika look like? For one, busy. I recently attended the event held by George Mason University’s biodefense program and [Read more] -
See what we’re reading this week at Global Biodefense on topics including discovery of a new species of Ebola virus in bats, new assay for quantifying abrin and ricin in blood, and the resurgence of HIV/AIDS. POLICY [Read more] -
See what we’re reading this week at Global Biodefense on topics including the spread of extensively drug-resistant typhoid in Middle East, Lyme disease vaccine Phase 1 trial, and FDA approval of freeze-dried plasma. POLICY + INITIATIVES Advancing [Read more]
